PARENT-CHILD INTERACTIONS IN FAMILIES WITH ANXIOUS CHILD

有焦虑儿童的家庭中的亲子互动

基本信息

  • 批准号:
    6614769
  • 负责人:
  • 金额:
    $ 8.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-04-01 至 2005-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal will be conducted in conjunction with an already awarded NIH K-Award given to Dr. Moira Rynn. That study will examine the effects of sertaline on reduction of anxious symptoms in children in an 8-week psychopharmacological trial. The assessments for the current study will be added to the protocol for the K-Award. While there are undoubtedly biological and societal contributions to the etiology and maintenance of childhood anxiety, parent-child relationships are also likely contributors. The current proposal seeks to better understand the nature of these relationships by examining the nature of interactions between parents and their anxious children. In additional to attributional styles (and biases), parents' use of psychological control has been observed as a correlate of children's anxious behavior and, together, these two constructs wilt be the focus of this proposal. Three areas of inquiry will guide this work: (I) description of the interactional styles of families with anxious children, (2) the impact of changes in the expression of children's symptoms on parenting behavior; and (3) an exploration of the mediational rote of psychological control in the relation between parent and child internalizing symptoms. Parent's use of psychological control, family expressions of attributional biases, children's expression of anxious symptoms, and parent's expression of anxious symptoms will be evaluated at pro-treatment and again 8-weeks later at post-treatment, The current proposal is unique in its design because child participants will undergo psychopharmacological intervention that has previously been found to reduce anxious symptoms by 50% in 90% of the sample. The intervention itself, therefore, will: (1) significantly reduce children's symptoms, and (2) have no direct impact on parenting behavior. This type of experimental manipulation of child behavior and the resultant impact of parenting provides a rare opportunity to examine the relationship between these constructs.
描述(由申请人提供):该提案将与已授予Moira Rynn博士的NIH K奖一起进行。该研究将在为期8周的精神药理学试验中检查舍他林对减少儿童焦虑症状的影响。本研究的评估将添加到K奖方案中。 虽然无疑有生物和社会的贡献的病因和维持儿童焦虑,亲子关系也可能是贡献者。目前的建议旨在通过研究父母与焦虑的孩子之间的互动性质,更好地了解这些关系的性质。 除了归因风格(和偏见),父母对心理控制的使用被观察到与儿童的焦虑行为相关,这两个结构将成为本建议的重点。 三个领域的调查将指导这项工作:(一)描述的家庭与焦虑的儿童的intermittent风格,(2)的影响,在儿童的症状的表达对父母的行为;(3)的中介机制的心理控制父母和孩子之间的关系内化症状的探索。在治疗前和治疗后8周再次评估父母对心理控制的使用、家庭对归因偏差的表达、儿童对焦虑症状的表达和父母对焦虑症状的表达,目前的提案在设计上是独一无二的,因为儿童参与者将接受精神药理学干预,此前已发现90%的患者焦虑症状减少50%样品的最大值。因此,干预本身将:(1)显着减少儿童的症状,(2)对养育行为没有直接影响。这种对儿童行为的实验性操纵以及由此产生的父母教养的影响为研究这些结构之间的关系提供了难得的机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VIRGINIA Salzer BURKS其他文献

VIRGINIA Salzer BURKS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VIRGINIA Salzer BURKS', 18)}}的其他基金

PARENT-CHILD INTERACTIONS IN FAMILIES WITH ANXIOUS CHILD
有焦虑儿童的家庭中的亲子互动
  • 批准号:
    6731121
  • 财政年份:
    2003
  • 资助金额:
    $ 8.5万
  • 项目类别:
PARENT-CHILD INTERACTIONS IN FAMILIES WITH ANXIOUS CHILD
有焦虑儿童的家庭中的亲子互动
  • 批准号:
    6938205
  • 财政年份:
    2003
  • 资助金额:
    $ 8.5万
  • 项目类别:

相似海外基金

Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
  • 批准号:
    10109165
  • 财政年份:
    2024
  • 资助金额:
    $ 8.5万
  • 项目类别:
    Launchpad
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
肯尼亚艾滋病毒感染妇女围产期情绪和焦虑障碍的分级护理一体化
  • 批准号:
    10677075
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
Understanding the Effects of Adolescent Nicotine Exposure on Increased Risk for Mood and Anxiety Disorders: Bridging the Gap from Pre-Clinical to Clinical Investigations
了解青少年尼古丁暴露对情绪和焦虑障碍风险增加的影响:弥合临床前研究与临床研究之间的差距
  • 批准号:
    478121
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
    Operating Grants
Addressing perinatal mood and anxiety disorders (PMADs) through a doula intervention
通过导乐干预解决围产期情绪和焦虑障碍 (PMAD)
  • 批准号:
    10861961
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
Evaluation of the effectiveness and implementation of online group cognitive behavioral therapy for perinatal women with anxiety disorders.
评估在线团体认知行为治疗对患有焦虑症的围产期妇女的有效性和实施情况。
  • 批准号:
    22KJ3164
  • 财政年份:
    2023
  • 资助金额:
    $ 8.5万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Investigating the error-related negativity and the balance N1 in children with anxiety disorders
调查焦虑症儿童的错误相关消极性和平衡 N1
  • 批准号:
    10685283
  • 财政年份:
    2022
  • 资助金额:
    $ 8.5万
  • 项目类别:
RESONY: Digital therapeutic to manage anxiety disorders
RESONY:管理焦虑症的数字疗法
  • 批准号:
    10042996
  • 财政年份:
    2022
  • 资助金额:
    $ 8.5万
  • 项目类别:
    Grant for R&D
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
  • 批准号:
    10705005
  • 财政年份:
    2022
  • 资助金额:
    $ 8.5万
  • 项目类别:
Developing an adjunctive mobile application for co-morbid substance use and anxiety disorders: comprehensive user experience testing of the Unwinding Anxiety application
开发针对共病药物使用和焦虑症的辅助移动应用程序:Unwinding Anxiety 应用程序的综合用户体验测试
  • 批准号:
    10597521
  • 财政年份:
    2022
  • 资助金额:
    $ 8.5万
  • 项目类别:
Investigating the role of neuroinflammation in environmental exposure-induced anxiety disorders
研究神经炎症在环境暴露诱发的焦虑症中的作用
  • 批准号:
    10573948
  • 财政年份:
    2022
  • 资助金额:
    $ 8.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了